Comparison of cervical esophagus dose-volumes for three radiotherapy techniques for head and neck cancer

Radiotherapy and Oncology

Volumn 87, Issue 2, 2008, Pages 274-280

  Chen, Jergin ^a   Shrieve, Dennis Charles ^a   Hitchcock, Ying Jia ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Esophageal dose; Head and neck cancer; Intensity modulated radiotherapy; Radiation technique

Indexed keywords

ARTICLE; CANCER LOCALIZATION; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; ESOPHAGUS; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; TUMOR VOLUME; UTERINE CERVIX;

ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DOSE FRACTIONATION; ESOPHAGUS; HEAD AND NECK NEOPLASMS; HUMANS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES;

EID: 43049162167     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.12.014     Document Type: Article

References (22)

1. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 (1998) 1798-1804
2. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
3. Jeremic B., Milicic B., Dagovic A., et al. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. J Clin Oncol 22 (2004) 3540-3548
4. Horiot J.C., Le Fur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25 (1992) 231-241
5. Calais G., Alfonsi M., Bardet E., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91 (1999) 2081-2086
6. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
7. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
8. Braam P.M., Roesink J.M., Moerland M.A., et al. Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 659-664
9. Chao K.S., Majhail N., Huang C.J., et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 61 (2001) 275-280
10. Singh A.K., Lockett M.A., and Bradley J.D. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 55 (2003) 337-341
11. Qiao W.B., Zhao Y.H., Zhao Y.B., et al. Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity. World J Gastroenterol 11 (2005) 2626-2629
12. Maguire P.D., Sibley G.S., Zhou S.M., et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 45 (1999) 97-103
13. Mavroidis P., Laurell G., Kraepelien T., et al. Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy. Acta Oncol 42 (2003) 865-881
14. Laurell G., Kraepelien T., Mavroidis P., et al. Stricture of the proximal esophagus in head and neck carcinoma patients after radiotherapy. Cancer 97 (2003) 1693-1700
15. Hirota S., Tsujino K., Endo M., et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy. Int J Radiat Oncol Biol Phys 51 (2001) 291-295
16. Gregoire V., Levendag P., Ang K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69 (2003) 227-236
17. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439
18. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
19. Roswit B. Complications of radiation therapy: the alimentary tract. Semin Roentgenol 9 (1974) 51-63
20. Amdur R.J., Li J.G., Liu C., et al. Unnecessary laryngeal irradiation in the IMRT era. Head Neck 26 (2004) 257-263 [discussion 263-54]
21. Mendenhall W.M., Parsons J.T., and Million R.R. Unnecessary irradiation of the normal larynx. Int J Radiat Oncol Biol Phys 18 (1990) 1531-1533
22. Chao K.S.C., and Ozyigit G. Intensity modulated radiation therapy for head & neck cancer. 1st ed. (2003), Lippincott Williams & Wilkins, Philadelphia, PA